Advertisement
Advertisement
AIDX
20/20 Biolabs, Inc. Common Stock
0.63
USDSponsored
0.00
+0.32%
Aug 31, 10:48 UTC -4
Open
AIDX Earnings Reports
Positive Surprise Ratio
AIDX beat 0 of 1 last estimates.
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
20/20 Biolabs, Inc. Common Stock earnings per share and revenue
On Aug 14, 2026, AIDX reported earnings of -0.25 USD per share (EPS) for Q2 26, missing the estimate of -0.12 USD, resulting in a -104.25% surprise. Revenue reached 731.00 thousand, compared to an expected 648.72 thousand, with a 12.68% difference. The market reacted with a +0.24% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
DocGo Inc. Common Stock
Report Date
Aug 17, 2026 For Q2 26
Estimate
-$0.06
Actual
-$0.16
Surprise
-153.16%
Intelligent Bio Solutions Inc. Common Stock
Report Date
Aug 19, 2026 For Q4 26
Estimate
-$1.61
Actual
-$0.90
Surprise
+44.15%
HealthEquity, Inc
Report Date
Aug 27, 2026 For Q2 27
Estimate
$1.20
Actual
$1.24
Surprise
+2.92%
Auna S.A.
Report Date
Aug 18, 2026 For Q2 26
Estimate
$0.87
Actual
$0.50
Surprise
-42.39%
FAQ
What were 20/20 Biolabs, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, 20/20 Biolabs, Inc. Common Stock reported EPS of -$0.25, missing estimates by -104.25%, and revenue of $731.00K, 12.68% above expectations.
How did the market react to 20/20 Biolabs, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 0.24%, changed from $0.55 before the earnings release to $0.55 the day after.
When is 20/20 Biolabs, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for 20/20 Biolabs, Inc. Common Stock's next earnings report?
Based on --
analysts, 20/20 Biolabs, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement